Quinapril Tablets USP 5 mg — Class III drug recall D-0650-2017
Terminated recall by Lupin Pharmaceuticals Inc., reported 2017-04-12, distributed nationwide. Failed Impurities/Degradation Specifications; Impurity A
| Recall number | D-0650-2017 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Lupin Pharmaceuticals Inc., Baltimore, MD, United States |
| Recall initiated | 2015-12-07 |
| Classified | 2017-04-06 |
| Reported by FDA | 2017-04-12 |
| Terminated | 2017-04-10 |
| Distributed | Nationwide (US) |
| Quantity | 15,168 bottes |
| Reason classes | specification failure |
| NDC | 68180-0554, 68180-0554-03, 68180-0554-09, 68180-0556, 68180-0556-09, 68180-0557, 68180-0557-03, 68180-0557-09, 68180-0558, 68180-0558-03, 68180-0558-09, 68180-0559, 68180-0559-03, 68180-0559-09 |
| Lot numbers | G303703 |
| Expiration dates | 2016-03 |
Product
Quinapril Tablets USP 5 mg, 90 count bottles, Lupin Pharmaceuticals, Inc., Baltimore, MD --- NDC 68180-556-09
Reason for recall
Failed Impurities/Degradation Specifications; Impurity A
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0650-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.